These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19778569)

  • 21. Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan.
    Liou YJ; Wang YC; Lin CC; Bai YM; Lai IC; Liao DL; Chen JY
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):483-6. PubMed ID: 15836802
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic variants of TP53 and EPHX1 in Leber's hereditary optic neuropathy and their relationship to age at onset.
    Ishikawa K; Funayama T; Ohde H; Inagaki Y; Mashima Y
    Jpn J Ophthalmol; 2005; 49(2):121-6. PubMed ID: 15838728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia.
    Kang SG; Lee HJ; Choi JE; An H; Rhee M; Kim L
    Hum Psychopharmacol; 2009 Jan; 24(1):55-60. PubMed ID: 19051221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
    Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
    Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer.
    Song SY; Jeong SY; Park HJ; Park SI; Kim DK; Kim YH; Shin SS; Lee SW; Ahn SD; Kim JH; Lee JS; Choi EK
    Lung Cancer; 2010 May; 68(2):278-82. PubMed ID: 19596483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
    Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
    Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
    Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
    Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
    Hori H; Ohmori O; Shinkai T; Kojima H; Okano C; Suzuki T; Nakamura J
    Neuropsychopharmacology; 2000 Aug; 23(2):170-7. PubMed ID: 10882843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between SOD2 or NQO1 genotypes and risk of bladder cancer.
    Terry PD; Umbach DM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):753-4. PubMed ID: 15767364
    [No Abstract]   [Full Text] [Related]  

  • 35. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
    Zhang Z; Zhang X; Hou G; Sha W; Reynolds GP
    J Psychiatr Res; 2002; 36(5):317-24. PubMed ID: 12127599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Val16Ala SOD2 polymorphism on the in-vitro effect of clomiphene citrate in oxidative metabolism.
    Costa F; Dornelles E; Mânica-Cattani MF; Algarve TD; Souza Filho OC; Sagrillo MR; Garcia LF; Cruz IB
    Reprod Biomed Online; 2012 Apr; 24(4):474-81. PubMed ID: 22386763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders.
    Pae CU; Yoon SJ; Patkar AA; Kim JJ; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):83-6. PubMed ID: 17644186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.